SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Bristol-Meyers Squibb

168

Bristol-Myers Squibb

BMY

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, pyschiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

CEO

Giovanni Caforio

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

New York, NY

Years on Fortune 500 List

22

Employees

25,000

Key Financials (last fiscal year)
$ millions% change
Revenues ($M)$16,5604.3%
Profits ($M)$1,565-21.9%
Assets ($M)$31,748
Total Stockholder Equity ($M)$14,266
Market Value — as of March 31, 2016 ($M)$106,848
Profit Ratios
Profit as % of Revenues9.5%
Profits as % of Assets4.9%
Profits as % of Stockholder Equity11.0%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)0.93
EPS % Change (from 2014)-22.5%
EPS % Change (5 year annual rate)-12.3%
EPS % Change (10 year annual rate)-4.8%
Total Return
Total Return to Investors (2015)19.3%
Total Return to Investors (5 year, annualized)25.2%
Total Return to Investors (10 year, annualized)16.4%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Bristol-Myers Squibb